CORNERSTONE THERAPEUTICS INC Business Operations Contracts & Agreements
25 Contracts & Agreements
- Collaboration Agreements (2 contracts)
- Development Agreements (6)
- Indemnification Agreements (1)
- Marketing Agreements (5)
- Sales Agreements (1)
- Services Agreements (3)
- Supply Agreements (4)
- Voting Agreements (3)
- VOTING AGREEMENT (Filed With SEC on November 7, 2013)
- SECOND AMENDMENT TO AMENDED AND RESTATED DEVELOPMENT AND MANUFACTURINGAGREEMENT (Filed With SEC on May 9, 2013)
- Leverage commercial capabilities by promoting respiratory and related products to high prescribing physicians through our respiratory sales force and to hospital-based healthcare... (Filed With SEC on March 3, 2011)
- EX-10.32 Amendment No. 1, dated December 18, 2009, to Supply and Marketing Agreement (Filed With SEC on March 4, 2010)
- EX-10.1 Amendment No. 1, dated June 16, 2009, to Development and Manufacturing Agreement (Filed With SEC on June 22, 2009)
- EX-10.1 Letter Amendment, dated June 12, 2009, to Manufacturing and Supply Agreement by and among Cornerstone Therapeutics Inc., Jagotec AG and SkyePharma PLC dated August 20, 2007 (Filed With SEC on June 18, 2009)
- EX-10.8 Voting Agreement, dated as of May 6, 2009 (Filed With SEC on May 12, 2009)
- EX-10.7 Voting Agreement, dated as of May 6, 2009, by and between the Company and Chiesi Farmaceutici SpA (Filed With SEC on May 12, 2009)
- Ex-10.1 Amendment No. 2, dated May 4, 2009, to Co-Promotion and Marketing Services Agreement with Dey, L.P (Filed With SEC on May 7, 2009)
- Ex-10.36 Form of Indemnification Agreement, entered into between Cornerstone BioPharma Holdings, Inc. and each of Craig Collard and Alastair McEwan (Filed With SEC on November 5, 2008)
- Ex-10.18 Supply and Marketing Agreement between Sovereign Pharmaceuticals, LTD and Aristos Pharmaceuticals, Inc. dated May 1, 2008 (Filed With SEC on November 5, 2008)
- Ex-10.17 Products Development Agreement between Neos Therapeutics, L.P. and Cornerstone BioPharma, Inc. dated August 27, 2008 (Filed With SEC on November 5, 2008)
- Ex-10.16 Development and Manufacturing Agreement by and among Neos Therapeutics, L.P., Coating Place, Inc. and Cornerstone BioPharma, Inc. effective February 27, 2008 (Filed With SEC on November 5, 2008)
- Ex-10.11 Joint Development Agreement between Meiji Seika Kaisha, Ltd. and Cornerstone BioPharma, Inc. dated February 11, 2008 (Filed With SEC on November 5, 2008)
- Ex-10.2 First Amendment dated November 5, 2007 to the Manufacturing Services Agreement by and between Patheon Pharmaceuticals Inc. and the Company dated May 9, 2007 (Filed With SEC on November 9, 2007)
- Ex-10.1 Manufacturing and Supply Agreement dated as of August 20, 2007 by and among the Company, Jagotec AG and SkyePharma PLC (Filed With SEC on November 9, 2007)
- Ex-10.5 Amendment No. 1 to Co-Promotion and Marketing Services Agreement (Filed With SEC on August 9, 2007)
- EX-10.5 Manufacturing Services Agreement between Patheon Pharmaceuticals, Inc. and the Registrant dated May 9, 2007 (Filed With SEC on May 10, 2007)
- EX-10.4 Amendment No. 1, dated May 9, 2007, to Agreement for Manufacturing and Supply of Zileuton effective February 8, 2005 by and between Shasun Pharma Solutions Limited and the... (Filed With SEC on May 10, 2007)
- EX-10.2 Co-Promotion and Marketing Services Agreement by and between the Registrant and Dey, L.P. dated March 13, 2007 (Filed With SEC on May 10, 2007)
- Ex-10.50 Amend. No.1 to the MedImmune Exclusive License and Collaboration Agreement (Filed With SEC on March 7, 2006)
- EX-10.3 Manufacturing Services Agreement between Patheon Pharmaceuticals Inc. and Critical Therapeutics, Inc (Filed With SEC on August 12, 2005)
- Ex-10.41 Agreement for Manufacturing and Supply (Filed With SEC on March 17, 2005)
- EX-10.25 DEVELOPMENT & SCALE-UP AGREEMENT (Filed With SEC on May 10, 2004)
- EX-10.8 EXCLUSIVE LICENSE & COLLABORATION AGMNT (Filed With SEC on March 19, 2004)
